Genedrive (GDR)

Sector:

Health Care

Index:

FTSE AIM All-Share

1.75p
   
  • Change Today:
    -0.075p
  • 52 Week High: 22.25p
  • 52 Week Low: 1.60p
  • Currency: UK Pounds
  • Shares Issued: 154.32m
  • Volume: 2,558,253
  • Market Cap: £2.70m
  • RiskGrade: 747

ShareCast News

Genedrive makes progress with Covid-19 test deve... 01-Jul-2021 ShareCast
Genedrive Covid-19 test formally approved in India 30-Apr-2021 ShareCast
Genedrive appointed to PHE microbiology supply f... 19-Apr-2021 ShareCast
Genedrive notifies FDA of intent to distribute C... 16-Dec-2020 ShareCast
Genedrive gets approval for Covid-19 kit in Sout... 30-Sep-2020 ShareCast
Genedrive revenues tumble as Covid-19 hits pre-e... 10-Jul-2020 ShareCast
Genedrive gets CE-mark for Covid-19 test kit 22-May-2020 ShareCast
Genedrives completes manufacturing milestone for... 01-May-2020 ShareCast
Genedrive upbeat on latest results from RNR1 kit... 03-Dec-2019 ShareCast
Genedrive infant hearing loss test gets CE mark 18-Nov-2019 ShareCast
Genedrive loss narrowed after double-digit reven... 03-Oct-2019 ShareCast
Genedrive losses narrow despite increased R&D co... 28-Mar-2019 ShareCast
Genedrive makes progress with HCV kit in first h... 15-Jan-2019 ShareCast
Genedrive to participate in three-country HCV th... 29-Nov-2018 ShareCast
Genedrive losses widen, announces £6m placing 16-Nov-2018 ShareCast
Genedrive revenues slip following completion of ... 13-Jul-2018 ShareCast
Genedrive and partners awarded grant for develop... 20-Jun-2018 ShareCast
Genedrive appoints former Alere Africa head to t... 09-Apr-2018 ShareCast
Genedrive presents hepatitis C assay in Singapore 03-Apr-2018 ShareCast
Genedrive awarded 'significant funding' for tube... 27-Feb-2018 ShareCast
Genedrive awarded £484,000 grant by Innovate UK 21-Nov-2017 ShareCast
Gendedrive inks second distribution agreement wi... 14-Nov-2017 ShareCast
Genedrive COO Allan Brown to leave 08-Nov-2017 ShareCast
Genedrive to launch decentralised Hepatitis C as... 02-Nov-2017 ShareCast
Genedrive to launch decentralised Hepatitis C as... 23-Oct-2017 ShareCast
Genedrive signs distribution agreement with Sysmex 16-Oct-2017 ShareCast
Genedrive attains CE marking for Hepatitis C ide... 11-Sep-2017 ShareCast
Genedrive announces additional US defence funding 27-Jul-2017 ShareCast
Genedrive posts solid revenue growth 13-Jul-2017 ShareCast
Genedrive's revenues rise despite difficulties i... 27-Jan-2017 ShareCast
Genedrive supplies field test units to US DoD 16-Jan-2017 ShareCast
Genedrive's revenue rises while it re-focuses co... 11-Oct-2016 ShareCast
Genedrive appoints Matthew Fowler CFO 21-Sep-2016 ShareCast
US DoD awards another £2m for Epistem biohazard ... 21-Mar-2016 ShareCast
Hangar 8 CEO makes first sale to meet demand for... 03-Dec-2013 ShareCast
EpiStem loses distribution contract for TB test 09-Sep-2013 ShareCast
Epistem to raise 4.3m pounds via placing 07-Dec-2012 ShareCast
Investec invests in Epistem 24-Oct-2012 ShareCast
Epistem delivers steady performance 16-Oct-2012 ShareCast
Epistem secures contract for TB test 06-Aug-2012 ShareCast
Small caps round-up: Epistem, Stadium Group, Tra... 05-Jul-2012 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genedrive Market Data

Currency UK Pounds
Share Price 1.75p
Change Today -0.075p
% Change -4.11 %
52 Week High 22.25p
52 Week Low 1.60p
Volume 2,558,253
Shares Issued 154.32m
Market Cap £2.70m
RiskGrade 747

Genedrive Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.43% below the market average12.43% below the market average12.43% below the market average12.43% below the market average12.43% below the market average
6.25% above the sector average6.25% above the sector average6.25% above the sector average6.25% above the sector average6.25% above the sector average
Price Trend
97.8% below the market average97.8% below the market average97.8% below the market average97.8% below the market average97.8% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
43.14% below the market average43.14% below the market average43.14% below the market average43.14% below the market average43.14% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average

Genedrive Dividends

No dividends found

Trades for 20-May-2024

Time Volume / Share Price
12:03 9,515 @ 1.70p
11:30 150,000 @ 1.74p
11:22 50,000 @ 1.74p
11:22 2,410 @ 1.75p
11:03 100,000 @ 1.74p

Genedrive Key Personnel

CFO Russell Shaw
CEO James Cheek

Top of Page